Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McLaughlin

Showing results (541-550 of 726) with videos related to

Pageof 73
Sort By:
The American Journal of Medicine|August 1, 1989
Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphomaF Cabanillas, S Pathak, G Grant, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 1, 2011
Peptides derived from the prohormone proNPQ/spexin are potent central modulators of cardiovascular and renal function and nociceptionLawrence Toll, Taline V Khroyan, Kemal Sonmez, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2012
Factors associated with chest wall toxicity after accelerated partial breast irradiation using high-dose-rate brachytherapySheree Brown, Frank Vicini, Jyotsna R Vanapalli, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2023
Tryptophan Substitution in CJ-15,208 (<i>cyclo</i>[Phe-D-Pro-Phe-Trp]) Introduces δ-Opioid Receptor Antagonism, Preventing Antinociceptive Tolerance and Stress-Induced Reinstatement of Extinguished Cocaine-Conditioned Place PreferenceKristen H Scherrer, Shainnel O Eans, Jessica M Medina, et al.
Blood|January 1, 1988
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)W S Velasquez, F Cabanillas, P Salvador, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangementP McLaughlin, F B Hagemeister, F Swan, et al.
Seminars in Oncology|October 1, 1993
New initiatives with fludarabine monophosphate in hematologic malignanciesM J Keating, S O'Brien, L E Robertson, et al.
Archives of General Psychiatry|September 15, 1998
Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem studyK Y Little, D P McLaughlin, L Zhang, et al.
Scientific Reports|September 19, 2019
An increased cell cycle gene network determines MEK and Akt inhibitor double resistance in triple-negative breast cancerVera E van der Noord, Ronan P McLaughlin, Marcel Smid, et al.
British Journal of Haematology|December 19, 1998
Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphomaA Younes, J Romaguera, O Mesina, et al.
Pageof 73

Showing results (541-550 of 726) with videos related to

Sort By:
Pageof 73
The American Journal of Medicine|August 1, 1989
Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphomaF Cabanillas, S Pathak, G Grant, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 1, 2011
Peptides derived from the prohormone proNPQ/spexin are potent central modulators of cardiovascular and renal function and nociceptionLawrence Toll, Taline V Khroyan, Kemal Sonmez, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2012
Factors associated with chest wall toxicity after accelerated partial breast irradiation using high-dose-rate brachytherapySheree Brown, Frank Vicini, Jyotsna R Vanapalli, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2023
Tryptophan Substitution in CJ-15,208 (<i>cyclo</i>[Phe-D-Pro-Phe-Trp]) Introduces δ-Opioid Receptor Antagonism, Preventing Antinociceptive Tolerance and Stress-Induced Reinstatement of Extinguished Cocaine-Conditioned Place PreferenceKristen H Scherrer, Shainnel O Eans, Jessica M Medina, et al.
Blood|January 1, 1988
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)W S Velasquez, F Cabanillas, P Salvador, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangementP McLaughlin, F B Hagemeister, F Swan, et al.
Seminars in Oncology|October 1, 1993
New initiatives with fludarabine monophosphate in hematologic malignanciesM J Keating, S O'Brien, L E Robertson, et al.
Archives of General Psychiatry|September 15, 1998
Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem studyK Y Little, D P McLaughlin, L Zhang, et al.
Scientific Reports|September 19, 2019
An increased cell cycle gene network determines MEK and Akt inhibitor double resistance in triple-negative breast cancerVera E van der Noord, Ronan P McLaughlin, Marcel Smid, et al.
British Journal of Haematology|December 19, 1998
Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphomaA Younes, J Romaguera, O Mesina, et al.
Pageof 73